Ulcerative Colitis (M14-234)

The purpose of the study is to evaluate the safety and efficacy of ABT-494 for induction and maintenance therapy in subjects with moderately to severely active ulcerative colitis.

Ulcerative colitis (UL-sur-uh-tiv koe-LIE-tis) is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining of your large intestine (colon) and rectum. Symptoms usually develop over time, rather than suddenly.

Source: www.MayoClinic.org


Register Today!

Trial Information

StatusOngoing Trial
Start DateSeptember 2016
End DateCompleted - in extension
Trial DurationUp to 61 weeks
Number of Visits8-18 Varies Depending
on Sub-study eligibility
Lead CRCAlexus McCue

For additional information
on this trial contact: